Topotecan Completed Phase 1 Trials for Esophageal Cancers / Lung Cancers / Malignant Lymphomas Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00002625Topotecan and Radiation Therapy in Treating Patients With Solid Tumors or Lymphoma